Cobalis Corporation
Cobalis - Investor Information
2007 SEC Filings
Filing Date
Form
Description   Downloads
11/14/2007
NT 10-Q
Notice of a Late Filing of Form 10-Q or 10-QSB  
11/1/2007
8-K
Report of unscheduled material events or corporate event  
10/17/2007
8-K
Report of unscheduled material events or corporate event  
8/20/2007
10QSB
Quarterly report which provides a continuing view of a company's financial position  
8/14/2007
NT 10-Q
Notice of a Late Filing of Form 10-Q or 10-QSB  
8/7/2007
8-K
Report of unscheduled material events or corporate event  
8/7/2007
8-K
Report of unscheduled material events or corporate event  
7/16/2007 
10KSB
Annual report which provides a comprehensive overview of the company for the past year  
6/29/2007 
NT 10-K 
Notice of a Late Filing of Form 10-K or 10-KSB  
6/4/2007
8-K
Report of unscheduled material events or corporate event  
5/2/2007
8-K
Report of unscheduled material events or corporate event  
4/20/2007 
4
Statement of changes in beneficial ownership of securities  
4/20/2007 
3
Initial filing by director officer or owner of more than ten percent  
4/13/2007
3
Initial filing by director officer or owner of more than ten percent  
4/13/2007
4
Statement of changes in beneficial ownership of securities  
4/13/2007 
4
Statement of changes in beneficial ownership of securities  
4/11/2007
S-8
Securities offered to employees pursuant to employee benefit plans  
4/5/2007
8-K
Report of unscheduled material events or corporate event  
3/22/2007
8-K
Report of unscheduled material events or corporate event  
3/19/2007 
EFFECT
Notice of Effectiveness  
3/9/2007
SB-2/A

Pre-effective Amendment No.1 to Form SB-2

 
3/1/2007 
8-K
Report of unscheduled material events or corporate event  
3/1/2007 
DEFA 14A
Proxy Statement Pursuant to Section 14(a)  
2/23/2007 
8-K
Report of unscheduled material events or corporate event  
2/20/2007 
SB-2
Registration of Securities to Be Sold to the Public  
2/20/2007 
8-K
Report of unscheduled material events or corporate event  
2/20/2007 
10QSB
Quarterly report which provides a continuing view of a company's financial position  
2/15/2007
NT 10-Q
Notice of a Late Filing of Form 10-Q or 10-QSB  
2/9/2007
DEF 14A
Definitive Proxy Information Statement Pursuant to Section 14(a) of the SEC Act  
1/22/2007
PRE 14A 

Preliminary Proxy Information Statement Pursuant to Section 14(a) of the SEC Act

 
1/3/2007
3
Initial filing by director officer or owner of more than ten percent  
 

IMPORTANT NOTICE:
The FDA has not completed evaluation of PreHistin™, and the information and statements contained in this web site are intended for informational purposes only. They are not meant to imply a cure or approved treatment for any disease or condition. You are encouraged to consult your physician for any healthcare questions or concerns you may have about your allergies.